Skip to main content

Table 4 Reasons for Discontinuation of HAIC Treatment with port system

From: Evaluation of percutaneous unilateral trans-femoral implantation of side-hole port-catheter system with coil only fixed-catheter-tip for hepatic arterial infusion chemotherapy

Reasons for Treatment Discontinuation

Numbers

Catheter irreversible dysfunction

16 (7.9%)

 Catheter occlusion

7 (3.5%)

 Hepatic arterial occlusion

8 (4.0%)

 Catheter dislocation

1 (0.5%)

Maintenance treatment without disease progression

45 (22.3%)

Disease progression during HAIC

 Extrahepatic lesions progression

38 (18.8%)

 Regrowth of hepatic lesions

32 (15.8%)

Grade 3/4 chemotherapy-related toxicity

18 (8.9%)

Rejection of treatment continuation

12 (5.9%)

Loss of follow up

16 (7.9%)

Hepatic surgery

4 (2.0%)